Real-world cost- effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China.

Yuliang XiangYingyao ChenZian XuShanyan ZhouZhiyong QinLingchao ChenDunming XiaoShimeng Liu

Published in: Journal of neuro-oncology (2024)

This cost-effectiveness analysis affirms that incorporating TTFields into TMZ treatment proves to be cost-effective, given a threshold three times the Chinese per capita GDP.

Keyphrases

newly diagnosed
replacement therapy
data analysis